Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
The article highlights recent insider transactions for penny stocks, including Bespoke Extracts, Ocuphire Pharma, and Duos Technologies. Insider buying can indicate confidence in the company's prospects.
May 22, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Duos Technologies CEO Charles Parker Ferry acquired 3,773 shares at $2.70 each, following weaker-than-expected first-quarter sales reported on May 13.
The CEO's purchase of shares following weak Q1 sales may indicate confidence in the company's future performance, which could positively impact the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Ocuphire Pharma CEO George Magrath acquired 5,000 shares at $1.75 each, despite the company posting a wider-than-expected quarterly loss on May 10.
Insider buying often signals confidence in the company's future. Despite recent losses, the CEO's purchase may indicate a belief in the company's long-term prospects.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80